{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:33Z","timestamp":1791849633909,"version":"4.3.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,28]]},"DOI":"10.7759\/cureus.17521","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T15:02:08Z","timestamp":1630162928000},"source":"Crossref","is-referenced-by-count":7,"title":["Past and Future Perspectives for Hepatitis B and C in Pakistan"],"prefix":"10.7759","author":[{"given":"Sarmad","family":"Zahoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sair Ahmad","family":"Tabraiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheraz","family":"Ansar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumera","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Ali","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.30.1800614","article-title":"Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU\/EEA: a systematic review","volume":"24","author":"Mason LM","year":"2019","unstructured":"Mason LM, Duffell E, Veldhuijzen IK, Petriti U, Bunge EM, Tavoschi L. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU\/EEA: a systematic review. Euro Surveill. 2019, 24:1800614. 10.2807\/1560-7917.ES.2019.24.30.1800614","journal-title":"Euro Surveill"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13371","article-title":"Disease burden of viral hepatitis A, B, C and E: a systematic analysis","volume":"27","author":"Liu Z","year":"2020","unstructured":"Liu Z, Shi O, Zhang T, Jin L, Chen X. Disease burden of viral hepatitis A, B, C and E: a systematic analysis. J Viral Hepat. 2020, 27:1284-96. 10.1111\/jvh.13371","journal-title":"J Viral Hepat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello A","year":"2016","unstructured":"Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016, 22:7824-40. 10.3748\/wjg.v22.i34.7824","journal-title":"World J Gastroenterol"},{"key":"ref4","unstructured":"Worldwide hepatitis statistics. Incidence and prevalence of the five types of hepatitis. (2020). Accessed. June 3, 2021: https:\/\/www.verywellhealth.com\/how-many-people-have-hepatitis-1760012."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2017.01.007","article-title":"Hepatitis B and C","volume":"64","author":"Karnsakul W","year":"2017","unstructured":"Karnsakul W, Schwarz KB. Hepatitis B and C. Pediatr Clin North Am. 2017, 64:641-58. 10.1016\/j.pcl.2017.01.007","journal-title":"Pediatr Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30333-3","article-title":"Funding the elimination of viral hepatitis: donors needed","volume":"2","author":"Gore C","year":"2017","unstructured":"Gore C, Hicks J, Deelder W. Funding the elimination of viral hepatitis: donors needed. Lancet Gastroenterol Hepatol. 2017, 2:843-5. 10.1016\/S2468-1253(17)30333-3","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061358","article-title":"Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review","volume":"20","author":"Kanda T","year":"2019","unstructured":"Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. Int J Mol Sci. 2019, 20:1358. 10.3390\/ijms20061358","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.06.032","article-title":"Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection","volume":"8","author":"Jacobson IM","year":"2010","unstructured":"Jacobson IM, Davis GL, El-Serag H, Negro F, Tr\u00e9po C. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2010, 8:924-33. 10.1016\/j.cgh.2010.06.032","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.06.019","article-title":"Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors","volume":"13","author":"Ali SA","year":"2009","unstructured":"Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009, 13:9-19. 10.1016\/j.ijid.2008.06.019","journal-title":"Int J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.29309\/TPMJ\/2019.26.09.1223","article-title":"Prevalence of hepatitis C virus among healthy donors at a large teaching hospital in Lahore, Pakistan: a cause of concern for health policy makers","volume":"26","author":"Hameed S","year":"2019","unstructured":"Hameed S, Abdullah SM, Ali A, Zahoor S, Butt RA, Zahoor S. Prevalence of hepatitis C virus among healthy donors at a large teaching hospital in Lahore, Pakistan: a cause of concern for health policy makers. Prof Med J. 2019, 26:1413-8. 10.29309\/TPMJ\/2019.26.09.1223","journal-title":"Prof Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-019-01081-5","article-title":"National prevalence rate of hepatitis B and C in Pakistan and its risk factors","volume":"28","author":"Mehmood S","year":"2019","unstructured":"Mehmood S, Raza H, Abid F, Saeed N, Rehman HM, Javed S, Khan MS. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. J. Public Health. 2019, 28:751-64. 10.1007\/s10389-019-01081-5","journal-title":"J. Public Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12878-016-0068-2","article-title":"Prevalence of transfusion transmissible infections in blood donors of Pakistan","volume":"16","author":"Arshad A","year":"2016","unstructured":"Arshad A, Borhany M, Anwar N, et al.. Prevalence of transfusion transmissible infections in blood donors of Pakistan. BMC Hematol. 2016, 16:27. 10.1186\/s12878-016-0068-2","journal-title":"BMC Hematol"},{"key":"ref13","article-title":"Association of ABO and Rh blood group types to hepatitis B, hepatitis C, HIV and syphilis infection, a five year\u2019 experience in healthy blood donors in a tertiary care hospital","volume":"29","author":"Batool Z","year":"2017","unstructured":"Batool Z, Durrani SH, Tariq S. Association of ABO and Rh blood group types to hepatitis B, hepatitis C, HIV and syphilis infection, a five year\u2019 experience in healthy blood donors in a tertiary care hospital. J Ayub Med Coll Abbottabad. 2017, 29:90-92.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref14","article-title":"Advances in the treatment of hepatitis C virus infection","volume":"8","author":"Jesudian AB","year":"2012","unstructured":"Jesudian AB, Gambarin-Gelwan M, Jacobson IM. Advances in the treatment of hepatitis C virus infection. Gastroenterol Hepatol (N Y). 2012, 8:91-101.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12028","article-title":"Current prospects for interferon-free treatment of hepatitis C in 2012","volume":"28","author":"Stedman CA","year":"2013","unstructured":"Stedman CA. Current prospects for interferon-free treatment of hepatitis C in 2012. J Gastroenterol Hepatol. 2013, 28:38-45. 10.1111\/jgh.12028","journal-title":"J Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/joah.joah_10_19","article-title":"Seroprevalence of hepatitis B virus in blood donors at a large teaching hospital of Pakistan: a potential health policy concern","volume":"10","author":"Abdullah S","year":"2019","unstructured":"Abdullah S, Zahoor S, Rao MA, Abdullah SM, Asif S, Wajid A, Zaidi AR. Seroprevalence of hepatitis B virus in blood donors at a large teaching hospital of Pakistan: a potential health policy concern. J Applied Hematol. 2019, 10:29-32. 10.4103\/joah.joah_10_19","journal-title":"J Applied Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302024","article-title":"Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis","volume":"62","author":"Zoutendijk R","year":"2013","unstructured":"Zoutendijk R, Reijnders JG, Zoulim F, et al.. Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis. Gut. 2013, 62:760-5. 10.1136\/gutjnl-2012-302024","journal-title":"Gut"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60171-past-and-future-perspectives-for-hepatitis-b-and-c-in-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:47Z","timestamp":1707507287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60171-past-and-future-perspectives-for-hepatitis-b-and-c-in-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.17521","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,28]]}}}